| Title: |
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study. |
| Authors: |
De Frémont, G. M.; Costedoat-Chalumeau, N.; Lazaro, E.; Belkhir, R.; Guettrot-Imbert, G.; Morel, N.; Nocturne, G.; Molto, A.; Goulenok, T.; Diot, E.; Perard, L.; Ferreira-Maldent, N.; Le Besnerais, M.; Limal, N.; Martis, N.; Abisror, N.; Debouverie, O.; Richez, C.; Sobanski, Vincent; Maurier, F.; Sauvetre, G.; Levesque, H.; Timsit, M. A.; Tieulié, N.; Orquevaux, P.; Bienvenu, B.; Mahevas, M.; Papo, T.; Lartigau-Roussin, C.; Chauvet, E.; Berthoux, E.; Sarrot-Reynauld, F.; Raffray, L.; Couderc, M.; Silva, N. M.; Jourde-Chiche, N.; Belhomme, N.; Thomas, T.; Poindron, V.; Queyrel-Moranne, V.; Delforge, J.; Le Ray, C.; Pannier, E.; Mariette, X.; Le Guern, V.; Seror, Raphaèle |
| Contributors: |
Université de Lille; Inserm; CHU Lille; Institute for Translational Research in Inflammation - U 1286 INFINITE; Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre |
| Publisher Information: |
Elsevier |
| Publication Year: |
2024 |
| Collection: |
LillOA (Lille Open Archive - Université de Lille) |
| Description: |
Background Adverse pregnancy outcomes in women with primary Sjögren's syndrome have only been evaluated retrospectively using heterogeneous methods and with contradictory results. We aimed to describe adverse pregnancy, delivery, and birth outcome risks in pregnant women with primary Sjögren's syndrome compared with those of a matched general population in France, and to identify factors predictive of disease flares or adverse pregnancy outcomes. Methods We conducted a multicentre, prospective, cohort study in France using the GR2 (Groupe de Recherche sur la Grossesse et les Maladies Rares) registry. Women from the GR2 study were eligible if they had conceived before March, 2021, had primary Sjögren's syndrome according to the American College of Rheumatology and European Alliance of Associations for Rheumatology (EULAR) 2016 classification criteria, and had an ongoing pregnancy at 12 weeks of gestation. In women who entered in the registry with pregnancies before 18 weeks of gestation, we sought to identify factors associated with primary Sjögren's syndrome flare (≥3-point increase in EULAR Sjögren's Syndrome Disease Activity Index [ESSDAI] score) or adverse pregnancy outcomes (fetal or neonatal death, placental insufficiency leading to a preterm delivery [ |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
Lancet Rheumatol; http://hdl.handle.net/20.500.12210/106920 |
| Availability: |
https://hdl.handle.net/20.500.12210/106920 |
| Rights: |
info:eu-repo/semantics/closedAccess |
| Accession Number: |
edsbas.BCD82CB6 |
| Database: |
BASE |